| Literature DB >> 23445708 |
Abstract
Microbial pathogens implicated in urinary tract infection and their antibiotic susceptibility patterns as prevalent in UTI symptomatic outpatients resident in Benin City, Nigeria was the focus of this study. One hundred (100) midstream urine samples were collected into sterile plastic universal bottles from outpatients who visited the University of Benin Teaching Hospital, Nigeria and who were tentatively diagnosed as manifesting symptoms of UTI. Patients were referred to the Medical Microbiology department by the consulting doctors. Significant bacterial counts and neutrophil (pus cells) counts were carried out on samples by standard methods. Positive samples for both counts were inoculated aseptically on sterile MacConkey agar, Cystine Lactose Electrolyte Deficient (CLED) agar and Sabouraud Dextrose agar plates and incubated appropriately. Microbial isolates were identified and antibiotic sensitivity testing was carried out on isolates by standard methods. Thirty nine (39.0%) and 61 (61.0%) samples recorded significant microbial growth and no growth respectively. Gram negative bacilli constituted 86.1% (of which enterobacteriaceae made up 49.9%) while gram positive cocci made up 13.9%. Strains of uropathogens isolated were Alcaligenes spp (19.4%), Klebsiella aerogenes (16.7%), Escherichia coli (13.9%), Staphylococcus aureus (13.9%), Candida albicans (11.1%), Proteus mirabilis (8.3%), Pseudomonas aeruginosa (5.5%), Enterobacter spp (5.5%) and Providencia spp (5.5%). Occurrence of UTI in male and female patients were 58.3% and 41.7% respectively of which UTI occurred highest in the 25-46, 15-54 and 27-54 age groups in that decreasing order. Alcaligenes spp occurred most in very old female patients. Candida albicans (the only fungal uropathogen) occurred in an 8day old male patient. Other isolates occurred in much older patients. A significantly high microscopic neutrophil count or pyuria was recorded from deposits of UTI positive patients (i.e. < 5/HPF). Eighteen (representing 50.5%) and 15 (47.8%) of total microbial strains isolated were sensitive to nitrofurantoin and ceftriaxone respectively. Antibiotic susceptibility profile also showed 13(41.6%), 13(41.6%), 13(41.6%) for ciprofloxacin, cefuroxime and ofloxacin respectively suggesting moderate sensitivity of the fluoroquinolones and second/third generation cephalosporins. Gentamicin, ampicillin and augmentin recorded over 70.0% resistance level each. A total of nineteen bacterial strains made of E.coli, Enterobacter spp, Proteus mirabilis, Providencia spp, Staph. aureus and Pseudomonas aeruginosa were multi drug resistant as they resisted 3, 3, 4, 4, 5 and 8 antibiotics respectively.Entities:
Mesh:
Year: 2013 PMID: 23445708 PMCID: PMC4776789 DOI: 10.5539/gjhs.v5n2p187
Source DB: PubMed Journal: Glob J Health Sci ISSN: 1916-9736
Frequency distribution of microbial pathogens in midstream urine of outpatients studied
| Microbial Isolates/Strains | No | Frequency% |
|---|---|---|
| 7 | 19.4 | |
| 6 | 16.7 | |
| 5 | 13.9 | |
| 5 | 13.9 | |
| 4 | 11.1 | |
| 3 | 8.3 | |
| 2 | 5.5 | |
| 2 | 5.5 | |
| 2 | 5.5 | |
Gram negative bacteria: 86.1%
Gram positive bacteria: 13.9%
Enterobacteriaceae: 49.9%
Non-Enterobacteriaceae: 50.1%
Sex distribution of uropathogens in midstream urine of outpatients studied
| Microbial Isolates/strains | No of strains | Males (%) | No of strains | Females (%) | Total |
|---|---|---|---|---|---|
| 4 | 19.1 | 3 | 20.0 | 7 | |
| 5 | 23.8 | 1 | 6.7 | 6 | |
| 2 | 9.5 | 3 | 20.0 | 5 | |
| 4 | 19.1 | 1 | 6.7 | 5 | |
| 1 | 4.8 | 3 | 20.0 | 4 | |
| 2 | 9.5 | 1 | 6.7 | 3 | |
| 0 | 0.0 | 2 | 13.3 | 2 | |
| 2 | 9.5 | 0 | 0.0 | 2 | |
| 1 | 4.8 | 1 | 6.7 | 2 | |
The age and sex distribution of microbial pathogens in relation to significant neutrophil (pus cells) counts in urine samples of patients
| Microbial Isolates/strains | Sex of Patients | Age Bracket of Patients showing sig cultural Yield (yrs) | Average age of Patients showing sig cultural yield (yrs) | Average neutrophil count/HPF |
|---|---|---|---|---|
| M (4) | 15-54 | 38 | 21 | |
| F (3) | 25-83 | 53 | NA | |
| M (5) | 25-46 | 34 | 19 | |
| F (1) | 15-33 | 24 | NA | |
| M (2) | 36-78 | 52 | 16 | |
| F (3) | 40-52 | 46 | NA | |
| M (4) | 27-54 | 44 | 10 | |
| F (1) | 33-50 | 42 | NA | |
| M (1) | 8days | 8days | 23 | |
| F (3) | 20-30 | 32 | 2 | |
| M (2) | 22-44 | 33 | 9 | |
| F (1) | 30-52 | 41 | NA | |
| M (0) | NA | NA | 6 | |
| F (2) | 18-47 | 33 | NA | |
| M (2) | 36-57 | 47 | 7 | |
| F (0) | NA | NA | NA | |
| M (1) | 30 | 30 | 6 | |
| F (1) | 46 | 46 | NA | |
| Total: | M (21) | |||
| F (15) |
NA, Not Available
HPF, High Power Focus
Susceptibility profile of uropathogenic bacterial organisms to selected antibiotics after 24 hours incubation at 37°C
| Microbial Isolates/strains | SELECTED ANTIBIOTICS USED | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CIP(%) | PN(%) | NIT(%) | CRO(%)R | GEN(%) | CRX(%) | OFX(%) | CXM(%) | CAZ(%) | AUG(%) | MEANS | ||||||||||||
| S | R | S | R | S | R | S | R | S | R | S | R | S | R | S | R | S | R | S | R | S | R | |
| 3 | 4 | 3 | 4 | 4 | 3 | 6 | 1 | 3 | 4 | 4 | 3 | 4 | 3 | 1 | 6 | 1 | 6 | 1 | 6 | 3 | 4 | |
| 42.9 | 57.1 | 42.9 | 57.1 | 57.1 | 42.9 | 85.7 | 14.3 | 42.9 | 57.1 | 57.1 | 42.9 | 57.1 | 42.9 | 14.3 | 85.7 | 14.3 | 85.7 | 14.3 | 85.7 | 42.9 | 57.1 | |
| 2 | 4 | 2 | 4 | 2 | 4 | 1 | 5 | 1 | 5 | 2 | 4 | 2 | 4 | 2 | 4 | 0 | 6 | 1 | 5 | 2 | 4 | |
| 33.3 | 66.7 | 33.3 | 66.7 | 33.3 | 66.7 | 16.7 | 83.3 | 16.7 | 83.3 | 33.3 | 66.7 | 33.3 | 66.7 | 33.3 | 66.7 | 0.0 | 100.0 | 16.7 | 83.3 | 33.3 | 66.7 | |
| 1 | 4 | 1 | 4 | 4 | 1 | 1 | 4 | 1 | 4 | 1 | 4 | 1 | 4 | 0 | 5 | 0 | 5 | 0 | 5 | 1 | 4 | |
| 20.0 | 80.0 | 20.0 | 80.0 | 80.0 | 20.0 | 20.0 | 80.0 | 20.0 | 80.0 | 20.0 | 80.0 | 20.0 | 80.0 | 0.0 | 100.0 | 0.0 | 100.0 | 0.0 | 100.0 | 20.0 | 80.0 | |
| 1 | 4 | 0 | 5 | 5 | 0 | 3 | 2 | 0 | 5 | 2 | 3 | 0 | 5 | 1 | 4 | 0 | 5 | 0 | 5 | 1 | 4 | |
| 20.0 | 80.0 | 0.0 | 100.0 | 100.0 | 0.0 | 60.0 | 40.0 | 0.0 | 100.0 | 40.0 | 60.0 | 0.0 | 100.0 | 20.0 | 80.0 | 0.0 | 100.0 | 0.0 | 100.0 | 20.0 | 80.0 | |
| 2 | 1 | 1 | 2 | 1 | 2 | 0 | 3 | 1 | 2 | 1 | 2 | 2 | 1 | 0 | 3 | 0 | 3 | 0 | 3 | 1 | 2 | |
| 66.7 | 33.3 | 33.3 | 66.7 | 33.3 | 66.7 | 0.0 | 100.0 | 33.3 | 66.7 | 33.3 | 66.7 | 66.7 | 33.3 | 0.0 | 100.0 | 0.0 | 100.0 | 0.0 | 100.0 | 33.3 | 66.7 | |
| 0 | 2 | 0 | 2 | 0 | 2 | 1 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 2 | |
| 0.0 | 100.0 | 0.0 | 100.0 | 0.0 | 100.0 | 50.0 | 50.0 | 0.0 | 100.0 | 50.0 | 50.0 | 50.0 | 50.0 | 0.0 | 100.0 | 0.0 | 100.0 | 0.0 | 100.0 | 0.0 | 100.0 | |
| 2 | 0 | 2 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 0 | 0 | 2 | 0 | 2 | 0 | 2 | 1 | 1 | |
| 100.0 | 0.0 | 100.0 | 0.0 | 50.0 | 50.0 | 50.0 | 50.0 | 50.0 | 50.0 | 50.0 | 50.0 | 100.0 | 0.0 | 0.0 | 100.0 | 0.0 | 100.0 | 0.0 | 100.0 | 50.0 | 50.0 | |
| 1 | 1 | 0 | 2 | 1 | 1 | 2 | 0 | 0 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 0 | 2 | 1 | 1 | |
| 50.0 | 50.0 | 0.0 | 100.0 | 50.0 | 50.0 | 100.0 | 0.0 | 0.0 | 100.0 | 50.0 | 50.0 | 50.0 | 50.0 | 50.0 | 50.0 | 0.0 | 100.0 | 0.0 | 100.0 | 50.0 | 50.0 | |
| TOTAL | 13 | 19 | 9 | 23 | 18 | 14 | 15 | 17 | 7 | 25 | 13 | 19 | 13 | 19 | 5 | 27 | 1 | 31 | 2 | 30 | ||
| n = 36(100.0%) | 41.6 | 58.4 | 28.7 | 71.3 | 50.5 | 49.5 | 47.8 | 52.2 | 20.4 | 79.6 | 41.6 | 58.4 | 41.6 | 58.4 | 14.7 | 85.3 | 14.3 | 85.7 | 22.7 | 77.3 | ||
Multidrug resistance occurrence of uropathogens in UTI cases of outpatients in study area
| Bacterial Isolates/strains | 3 drugs | 4 drugs | 5 drugs | Above 6 drugs |
|---|---|---|---|---|
| + | - | - | - | |
| + | - | - | - | |
| - | + | - | - | |
| - | + | - | - | |
| - | - | + | - | |
| - | - | - | + | |